Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Catalent shares up almost 60% in 2023 as acquisition rumors swirl

By Brian Buntz | February 7, 2023

CatalentContract manufacturing giant Catalent (NYSE:CTLT) is rumored to be the target of a Danaher (NYSE:DHR) acquisition, according to a Bloomberg report.

CTLT shares were trading at $72.15 in afternoon trading on Tuesday, an increase of 58.75% over its valuation at the beginning of 2023.

The company’s market cap is close to $13 billion.

If the deal moves forward, it could help Danaher compete against Thermo Fisher Scientific (NYSE:TMO), whose market cap is $226.36 billion.

Two diversified life sciences companies

Catalent offers a range of advanced delivery technologies, development, and manufacturing services for drugs, biologics, gene therapies and consumer health products. Its offerings are diverse, spanning oral, topical, inhalation and injectable drug delivery as well as biologics.

Thermo Fisher Scientific’s traditional focus is on analytical instruments, reagents and services for research, analysis and diagnostics. The company has a variety of life science customers, including those specializing in biopharmaceuticals and biotechnology.

Thermo Fisher acquired Patheon, a contract development and manufacturing organization CDMO, in 2017 and PPD, a contract research organization, in 2021.

Last year was hard for Catalent

2022 was a rough year for Catalent. The company’s stock fell from $115.46 at the beginning of the year to $52.25 at the end of it.

At the end of 2022, the company laid off 400 temporary and full-time workers in Bloomington, Indiana and over 210 employees in Texas and Maryland.

Catalent also stopped construction on the Vaccine Manufacturing and Innovation Centre near Oxford in the United Kingdom, according to media reports.

In Q4 2022, Catalent reported $1.15 billion in revenue, a 5.6% decrease compared to the previous year. In addition, the earnings per share (EPS) for the same period were $0.67, a drop from the prior year’s EPS of $0.90.

Nevertheless, the reported revenue exceeded the Zacks Consensus Estimate of $1.12 billion, beating expectations by 2.41%. EPS, however, fell short of the consensus estimate of $0.72, resulting in a miss of –6.94%.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE